Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020

Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020

Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity

RELEASE DATE
11-Dec-2020
REGION
North America
Deliverable Type
Market Research
Research Code: K56B-01-00-00-00
SKU: HC03364-NA-MT_25029
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC03364-NA-MT_25029

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry.

The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recent COVID-19 pandemic. Clinical laboratories and manufacturers have been vying to develop SARS-Cov-2 assays to serve the rising demand for testing. In these uncertain times, mergers, acquisitions, and partnerships have seen a considerable dip as compared with the previous year.

The US government and healthcare agencies are supporting telehealth and innovative and clinically vetted direct-to-consumer diagnostic testing services. Partnerships with digital vendors and automation companies are expected to empower core diagnostic companies with Internet of Things (IoT), cloud, and Big Data capabilities. Given these trends, it is important to understand the market dynamics to remain competitive and successful in the in vitro diagnostics market.

This report offers insightful analysis in the form of key growth opportunities that center on the use of serological testing, unmet testing needs for neurodegenerative disorders, process flow improvement through IoT technologies, and the opportunity to include direct-to-consumer capabilities in business models.


Research Highlights 

• Market drivers and restraints

• Recent product trends and business updates from the US market

• Growth opportunities

• Strategic imperatives

Author: Amol Dilip Jadhav

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the US In Vitro Diagnostics Clinical Chemistry and Immunoassay Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Drivers

Growth Restraints

Merger, Acquisition, and Partnership Activities

Select Product-related Activities

Select Product-related Activities (continued)

Growth Opportunity 1: Serology Assays for COVID-19 Diagnosis

Growth Opportunity 1: Serology Assays for COVID-19 Diagnosis (continued)

Growth Opportunity 2: Biomarkers for Alzheimer’s Disease Diagnosis

Growth Opportunity 2: Biomarkers for Alzheimer’s Disease Diagnosis (continued)

Growth Opportunity 3: IoT for Optimizing Process Flow

Growth Opportunity 3: IoT for Optimizing Process Flow (continued)

Growth Opportunity 4: Direct-to-Consumer Testing Services

Growth Opportunity 4: Direct-to-Consumer Testing Services (continued)

List of Exhibits

Legal Disclaimer

The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recent COVID-19 pandemic. Clinical laboratories and manufacturers have been vying to develop SARS-Cov-2 assays to serve the rising demand for testing. In these uncertain times, mergers, acquisitions, and partnerships have seen a considerable dip as compared with the previous year. The US government and healthcare agencies are supporting telehealth and innovative and clinically vetted direct-to-consumer diagnostic testing services. Partnerships with digital vendors and automation companies are expected to empower core diagnostic companies with Internet of Things (IoT), cloud, and Big Data capabilities. Given these trends, it is important to understand the market dynamics to remain competitive and successful in the in vitro diagnostics market. This report offers insightful analysis in the form of key growth opportunities that center on the use of serological testing, unmet testing needs for neurodegenerative disorders, process flow improvement through IoT technologies, and the opportunity to include direct-to-consumer capabilities in business models.--BEGIN PROMO--

Research Highlights 

• Market drivers and restraints

• Recent product trends and business updates from the US market

• Growth opportunities

• Strategic imperatives

Author: Amol Dilip Jadhav

More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Amol Dilip Jadhav
Industries Healthcare
WIP Number K56B-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9562-B1,9627-B1